Marketing-authorisation holder · Canada
Csl Behring Canada Inc
43 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
43 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 43
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALBUREX - 2525 % · Solution | Albumin | Canada | Marketed | 2007 |
| ALBUREX - 55 % · Solution | Albumin | Canada | Marketed | 2008 |
| ANDEMBRY200 mg / 1.2 ml · Solution | Garadacimab | Canada | Authorised | |
| ANDEMBRY200 mg / 1.2 ml · Solution | Garadacimab | Canada | Marketed | 2025 |
| BERINERT 15001500 unit / vial · Kit, Powder For Solution | C1 esterase inhibitor | Canada | Marketed | 2015 |
| BERINERT 500500 unit / vial · Kit, Powder For Solution | C1 esterase inhibitor | Canada | Marketed | 2010 |
| BERIPLEX P/N 10001600 unit + 1240 unit + 1000 unit + 2040 unit + 1640 unit + 1360 unit · Powder For Solution | Coagulation factor ii, Coagulation factor ix, Antihemophilic factor, Coagulation factor x, Protein c, Protein s | Canada | Marketed | 2013 |
| BERIPLEX P/N 500800 unit + 620 unit + 500 unit + 1020 unit + 820 unit + 680 unit · Powder For Solution | Coagulation factor ii, Coagulation factor ix, Antihemophilic factor, Coagulation factor x, Protein c, Protein s | Canada | Marketed | 2011 |
| CORIFACT 12501250 unit / vial · Powder For Solution | Coagulation factor xiii | Canada | Marketed | 2014 |
| CORIFACT 250250 unit / vial · Powder For Solution | Coagulation factor xiii | Canada | Marketed | 2014 |
| HAEGARDA3000 unit / vial · Kit, Powder For Solution | C1 esterase inhibitor | Canada | Marketed | 2020 |
| HAEGARDA2000 unit / vial · Kit, Powder For Solution | C1 esterase inhibitor | Canada | Marketed | 2020 |
| HEMGENIX10000000000000 genome copies / ml · Suspension | Etranacogene dezaparvovec | Canada | Marketed | 2026 |
| HIZENTRA200 mg / ml · Solution | Immunoglobulin | Canada | Marketed | 2024 |
| HIZENTRA200 mg / ml · Solution | Immunoglobulin | Canada | Marketed | 2017 |
| HIZENTRA200 mg / ml · Solution | Immunoglobulin | Canada | Marketed | 2017 |
| HIZENTRA200 mg / ml · Solution | Immunoglobulin | Canada | Not marketed | 2011 |
| HIZENTRA200 mg / ml · Solution | Immunoglobulin | Canada | Marketed | 2021 |
| HUMATE-P1000 unit / 15 ml + 2400 unit / 15 ml · Powder For Solution | Antihemophilic factor, Von willebrand factor | Canada | Marketed | 2004 |
| HUMATE-P250 unit / 5 ml + 600 unit / 5 ml · Powder For Solution | Antihemophilic factor, Von willebrand factor | Canada | Marketed | 2004 |
| HUMATE-P500 unit / 10 ml + 1200 unit / 10 ml · Powder For Solution | Antihemophilic factor, Von willebrand factor | Canada | Marketed | 2004 |
| IDELVION250 unit / vial · Kit, Powder For Solution | Coagulation factor ix | Canada | Authorised | |
| IDELVION3500 unit / vial · Kit, Powder For Solution | Coagulation factor ix | Canada | Authorised | |
| IDELVION1000 unit / vial · Kit, Powder For Solution | Coagulation factor ix | Canada | Not marketed | 2019 |
| IDELVION500 unit / vial · Kit, Powder For Solution | Coagulation factor ix | Canada | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 43 | 31 | 12 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.